Physician

Thomas M. Reilly, M.D.

According to 2025 Medicare claims, Thomas Reilly, M.D. (NPI: 1861597387) practices orthopedic surgery in the Kokomo, IN market, with the plurality of this provider's patient population coming from Howard, IN. This provider's primary affiliated billing organization is INDIANA SPINE GROUP, PC (NPI: 1609960046; TIN: 35-2149412) and primary practice location at 46901-5148. Reilly is affiliated with the CHSPSC ACO 2, LLC (ACO ID: A3664), participating under the MSSP model.

Reilly's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 191 traditional Medicare patients, billed 706 HCPCS/CPT codes, and received $117,819 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 290 prescription claims across 128 beneficiaries totaling $3,013 in drug costs, led by Pregabalin (Pregabalin). 2018 DME data shows 13 claims. Open Payments data shows 15 records totaling $410. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $511,418 to $117,819. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $234,605 to $3,013. For DME billing, reported payments started with an early spike, then settled into a lower baseline, moving from $26,322 to $3,885.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	638	2,520	$511,418
2016	644	3,042	$600,425
2017	510	2,152	$379,753
2018	339	1,592	$295,234
2019	306	1,502	$322,484
2020	314	1,795	$259,190
2021	283	1,227	$241,544
2022	265	1,115	$217,416
2023	210	805	$153,432
2024	191	706	$117,819

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	377	1,604	$234,605
2016	378	1,479	$178,588
2017	328	1,066	$80,175
2018	277	862	$41,599
2019	227	679	$30,570
2020	232	700	$12,991
2021	212	608	$12,718
2022	199	547	$9,912
2023	142	341	$5,085
2024	128	290	$3,013

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	27	39	$91,135
2017	N/R	31	$1,055
2018	N/R	13	$307
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	43	43	$104
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	58	73	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	33	38	$53
72050	X-ray of upper spine, 4-5 views	28	29	$31
72110	X-ray of lower and sacral spine, minimum of 4 views	63	64	$30

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Pregabalin	Pregabalin	62	1,541	$712
Gabapentin	Gabapentin	70	2,355	$655
Diclofenac Sodium	Diclofenac Sodium	58	1,728	$475
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	26	174	$424
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	95	$188

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	15	$410	Intrinsic Therapeutics
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Thomas M. Reilly, M.D.?

Tedicare shows public-source Medicare data for Thomas M. Reilly, M.D. (NPI 1861597387), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thomas M. Reilly, M.D. have ACO affiliation data?

Thomas M. Reilly, M.D. is shown with ACO affiliation data for CHSPSC ACO 2, LLC (MSSP, ACO ID A3664).

What billing organization is linked to Thomas M. Reilly, M.D.?

Thomas M. Reilly, M.D. is linked to INDIANA SPINE GROUP, PC (billing NPI 1609960046) in the available physician profile data.

Does Thomas M. Reilly, M.D. have Open Payments data?

Thomas M. Reilly, M.D. has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.